The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Novartis
Approval Status: Approved June 1999
Treatment for: Cardiology
General Information
Lescol has been approved as a treatment for the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia.